FDA Inspection 1010514 — Sparsha Pharma Usa Inc
The FDA completed an inspection of Sparsha Pharma Usa Inc on Apr 28, 2017 in Oceanside, CA. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Devices.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Apr 28, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Oceanside, CA (United States)